Stockreport

Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]

Unicycive Therapeutics, Inc.  (UNCY) 
PDF clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced enrollment has been completed i [Read more]